Pfizer Reports First-Quarter 2024 Results

Go back to Pfizer Reports First-Quarter 2024 Results

Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates

May 1, 2024 6:53 AM UTC

Pfizer (NYSE: PFE) shares rose 3% in premarket trading Wednesday after the drugmaker reported Q1 earnings and revenue that beat analyst estimates.

Earnings per share (EPS) stood at $0.82, exceeding the consensus estimates of $0.53. Revenue came in at $14.9 billion, also above the consensus projection of $14.04 billion.

Meanwhile, adjusted research and development (R&D) expenses... More

Pfizer (PFE) Tops Q1 EPS by 29c, Beats on Revenue; Offers FY24 Guidance

May 1, 2024 6:46 AM UTC

Pfizer (NYSE: PFE) reported Q1 EPS of $0.82, $0.29 better than the analyst estimate of $0.53. Revenue for the quarter came in at $14.9 billion versus the consensus estimate of $14.04 billion.

GUIDANCE:

Pfizer sees FY2024 EPS of $2.15-$2.35, versus the consensus of $2.21. Pfizer sees... More